Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Economic Studies of FDA Regulations

Solicitation Number: 13-223-SOL-00047
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Location: Office of Acquisitions and Grants Services
  • Print

Note:

There have been modifications to this notice. To view the most recent modification/amendment, click here
:
13-223-SOL-00047
:
Combined Synopsis/Solicitation
:
Added: Jun 21, 2013 10:03 am
The Economics Staff of the Food and Drug Administration's (FDA) Office of Planning (OPl) has a requirement to provide accurate and timely economic assessments of FDA regulatory actions. These analyses have high public visibility and, therefore, must withstand intense scientific and technical review and scrutiny by diverse audiences including the public, regulated entities, Government agencies such as the Department of Health and Human Services and the Office of Management and Budget, the U.S. Congress, professional economists, and the scientific and medical community. The need of the Economics Staff for support by a contractor arises from the variety and complexity of the work, the need to have access to specialized resources to rapidly gather data to meet tight deadlines, and the need for research involving direct contact with regulated entities.

See attached RFP for further details. 
Added: Jul 02, 2013 10:04 am

The purpose of this amendment is to post responses to questions, set a deadline for questions and correct a reference to section C.4.A.


Please see the attachment "Amendment 2 Questions" for Government responses.


A deadline of July 16, 2013 at 4:30 PM EST for questions of is hereby added to this solicitation. All questions submitted after this deadline may or may not receive a response.


All references to section C.4.A are hereby replaced with 2.4.A which can be located on page 5 of the solicitation.


 

Added: Jul 10, 2013 1:52 pm

The purpose of this amendment is to post responses to questions received for this solicitation. Please see attached for FDA responses to questions.

Please consult the list of document viewers if you cannot open a file.

13-223-SOL-00047

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
13-223-SOL-00047
Posted Date:
June 21, 2013
Description: Solicitation for Economic Studies of FDA Regulations IDIQ contract.
Description: Past Performance Questionnaire Form

Amendment 1

Type:
Mod/Amendment
Posted Date:
June 24, 2013
Description: The purpose of this amendment is to adjust box 8 of the 1449 solicitation cover page. Box 8 is hereby adjusted to read 7/23/2013. Please see attached for revised solicitation.

Amendment 2

Type:
Mod/Amendment
Posted Date:
July 2, 2013
Description: Question responses

Responses to Questions

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Responses to Questions
Posted Date:
July 10, 2013
Description: Responses to Questions.

Responses to Questions

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Responses to Questions
Posted Date:
July 22, 2013
Description: Responses to questions.
:
5630 Fishers Lane, Room 2129
Rockville, Maryland 20857-0001
:
Sean Wybenga
Phone: 301-827-6761
: